微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -14.68% | 37.74% | -51.81% | 143/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -9.67% | 45.52% | -235.76% | 143/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -2.88% | 59.21% | 94.32% | 135/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -50.71% | -279.85% | -115.06% | 145/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -23.58% | -232.11% | -32.85% | 146/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -17.75% | -516.32% | -151.42% | 147/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -7.06% | -702.27% | 47.12% | 140/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -13.35% | -130.97% | -88.03% | 131/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -7.1% | -153.57% | -146.53% | 126/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -2.88% | 30.6% | -227.27% | 130/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.88% | -383.87% | 84.78% | 123/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -5.78% | -2323.08% | -106.43% | 125/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -2.8% | -206.87% | 32.53% | 120/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -4.15% | -780.33% | -1438.71% | 132/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.31% | -3.13% | 19.23% | 108/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.26% | 138.81% | -90.08% | 111/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.62% | 4.8% | 329.51% | 88/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.61% | 510% | 90.63% | 104/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.32% | -76.64% | 147.76% | 83/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -0.67% | -140.85% | -126.8% | 119/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.5% | 127.27% | 2400% | 94/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.1% | -86.11% | -92.7% | 108/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.37% | -36.87% | -16.46% | 73/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 1.64% | -70.66% | 49.09% | 113/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.1% | -79.48% | 52.78% | 97/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 0.72% | -84.78% | -66.82% | 98/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.17% | -40.22% | -61.18% | 50/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 5.59% | -52.71% | 4.29% | 81/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.36% | -51.76% | 13.32% | 63/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.73% | -33.19% | 30.3% | 49/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.63% | -31.38% | -69.29% | 15/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 11.82% | -53.72% | 6.39% | 44/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 11.11% | -50.8% | 56.92% | 21/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 7.08% | -61.14% | 33.84% | 27/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 5.29% | -66.02% | -79.29% | 11/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 25.54% | -54.95% | 13.11% | 15/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 22.58% | -48.62% | 23.93% | 5/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 18.22% | 2% | 17.02% | 2/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 15.57% | 2% | -72.53% | 1/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |